Aasebø, E.; Brenner, A.K.; Hernandez-Valladares, M.; Birkeland, E.; Mjaavatten, O.; Reikvam, H.; Selheim, F.; Berven, F.S.; Bruserud, Ø.
Patient Heterogeneity in Acute Myeloid Leukemia: Leukemic Cell Communication by Release of Soluble Mediators and Its Effects on Mesenchymal Stem Cells. Diseases 2021, 9, 74.
https://doi.org/10.3390/diseases9040074
AMA Style
Aasebø E, Brenner AK, Hernandez-Valladares M, Birkeland E, Mjaavatten O, Reikvam H, Selheim F, Berven FS, Bruserud Ø.
Patient Heterogeneity in Acute Myeloid Leukemia: Leukemic Cell Communication by Release of Soluble Mediators and Its Effects on Mesenchymal Stem Cells. Diseases. 2021; 9(4):74.
https://doi.org/10.3390/diseases9040074
Chicago/Turabian Style
Aasebø, Elise, Annette K. Brenner, Maria Hernandez-Valladares, Even Birkeland, Olav Mjaavatten, Håkon Reikvam, Frode Selheim, Frode S. Berven, and Øystein Bruserud.
2021. "Patient Heterogeneity in Acute Myeloid Leukemia: Leukemic Cell Communication by Release of Soluble Mediators and Its Effects on Mesenchymal Stem Cells" Diseases 9, no. 4: 74.
https://doi.org/10.3390/diseases9040074
APA Style
Aasebø, E., Brenner, A. K., Hernandez-Valladares, M., Birkeland, E., Mjaavatten, O., Reikvam, H., Selheim, F., Berven, F. S., & Bruserud, Ø.
(2021). Patient Heterogeneity in Acute Myeloid Leukemia: Leukemic Cell Communication by Release of Soluble Mediators and Its Effects on Mesenchymal Stem Cells. Diseases, 9(4), 74.
https://doi.org/10.3390/diseases9040074